Valsamo Anagnostou
Valsamo Anagnostou
Johns Hopkins School of Medicine
E-mail megerősítve itt:
Hivatkozott rá
Hivatkozott rá
Neoadjuvant PD-1 blockade in resectable lung cancer
PM Forde, JE Chaft, KN Smith, V Anagnostou, TR Cottrell, MD Hellmann, ...
New England Journal of Medicine 378 (21), 1976-1986, 2018
Programmed death ligand-1 expression in non-small cell lung cancer
V Velcheti, KA Schalper, DE Carvajal, VK Anagnostou, KN Syrigos, ...
Laboratory investigation 94 (1), 107-116, 2014
Antibody validation
J Bordeaux, AW Welsh, S Agarwal, E Killiam, MT Baquero, JA Hanna, ...
Biotechniques 48 (3), 197-209, 2010
Direct detection of early-stage cancers using circulating tumor DNA
J Phallen, M Sausen, V Adleff, A Leal, C Hruban, J White, V Anagnostou, ...
Science translational medicine 9 (403), 2017
Evolution of neoantigen landscape during immune checkpoint blockade in non–small cell lung cancer
V Anagnostou, KN Smith, PM Forde, N Niknafs, R Bhattacharya, J White, ...
Cancer discovery 7 (3), 264-276, 2017
Personalized genomic analyses for cancer mutation discovery and interpretation
S Jones, V Anagnostou, K Lytle, S Parpart-Li, M Nesselbush, DR Riley, ...
Science translational medicine 7 (283), 283ra53-283ra53, 2015
GOLPH3 modulates mTOR signalling and rapamycin sensitivity in cancer
KL Scott, O Kabbarah, MC Liang, E Ivanova, V Anagnostou, J Wu, ...
Nature 459 (7250), 1085-1090, 2009
The genomic landscape of response to EGFR blockade in colorectal cancer
A Bertotti, E Papp, S Jones, V Adleff, V Anagnostou, B Lupo, M Sausen, ...
Nature 526 (7572), 263-267, 2015
Clinical implications of genomic alterations in the tumour and circulation of pancreatic cancer patients
M Sausen, J Phallen, V Adleff, S Jones, RJ Leary, MT Barrett, ...
Nature communications 6 (1), 1-6, 2015
Genome-wide cell-free DNA fragmentation in patients with cancer
S Cristiano, A Leal, J Phallen, J Fiksel, V Adleff, DC Bruhm, SØ Jensen, ...
Nature 570 (7761), 385-389, 2019
Cancer immunotherapy: a future paradigm shift in the treatment of non–small cell lung cancer
VK Anagnostou, JR Brahmer
Clinical Cancer Research 21 (5), 976-984, 2015
Epigenetic therapy ties MYC depletion to reversing immune evasion and treating lung cancer
MJ Topper, M Vaz, KB Chiappinelli, CEDS Shields, N Niknafs, RWC Yen, ...
Cell 171 (6), 1284-1300. e21, 2017
Gefitinib or placebo in combination with tamoxifen in patients with hormone receptor–positive metastatic breast cancer: a randomized phase II study
CK Osborne, P Neven, LY Dirix, JR Mackey, J Robert, C Underhill, ...
Clinical Cancer Research 17 (5), 1147-1159, 2011
Pathologic features of response to neoadjuvant anti-PD-1 in resected non-small-cell lung carcinoma: a proposal for quantitative immune-related pathologic response criteria (irPRC)
TR Cottrell, ED Thompson, PM Forde, JE Stein, AS Duffield, ...
Annals of Oncology 29 (8), 1853-1860, 2018
Thyroid transcription factor 1 is an independent prognostic factor for patients with stage I lung adenocarcinoma
VK Anagnostou, KN Syrigos, G Bepler, RJ Homer, DL Rimm
Journal of clinical oncology 27 (2), 271-278, 2009
Quantitative assessment of effect of preanalytic cold ischemic time on protein expression in breast cancer tissues
VM Neumeister, V Anagnostou, S Siddiqui, AM England, ER Zarrella, ...
JNCI: Journal of the National Cancer Institute 104 (23), 1815-1824, 2012
Dynamics of tumor and immune responses during immune checkpoint blockade in non–small cell lung cancer
V Anagnostou, PM Forde, JR White, N Niknafs, C Hruban, J Naidoo, ...
Cancer research 79 (6), 1214-1225, 2019
Analytic variability in immunohistochemistry biomarker studies
VK Anagnostou, AW Welsh, JM Giltnane, S Siddiqui, C Liceaga, ...
Cancer Epidemiology and Prevention Biomarkers 19 (4), 982-991, 2010
Ipilimumab plus nivolumab and DNA-repair defects in AR-V7-expressing metastatic prostate cancer
K Boudadi, DL Suzman, V Anagnostou, W Fu, B Luber, H Wang, ...
Oncotarget 9 (47), 28561, 2018
Immuno-oncology trial endpoints: capturing clinically meaningful activity
V Anagnostou, M Yarchoan, AR Hansen, H Wang, F Verde, E Sharon, ...
Clinical Cancer Research 23 (17), 4959-4969, 2017
A rendszer jelenleg nem tudja elvégezni a műveletet. Próbálkozzon újra később.
Cikkek 1–20